×
Please click
here
if you are not redirected within a few seconds.
All
Maps
News
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Avenue Therapeutics' Shares March Higher, Can It Continue?
Yahoo Movies UK
As of late, it has definitely been a great time to be an investor in Avenue Therapeutics, Inc. ATXI. The stock has moved higher by 16.8% in the past month,...
18 hours ago
Avenue Therapeutics Announces Reverse Stock Split
GlobeNewswire
MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical...
1 month ago
Avenue Therapeutics to enact reverse stock split By Investing.com
Investing.com
In a strategic move, Avenue Therapeutics Inc . (NASDAQ: NASDAQ:ATXI) has announced a reverse stock split, as per a recent 8K SEC filing.
3 months ago
Why Is Avenue Therapeutics (ATXI) Stock Up 59% Today?
InvestorPlace
Avenue Therapeutics stock is rising higher on Wednesday following news of an investor taking a 14.5% stake in ATXI shares.
6 months ago
Why Avenue Therapeutics (ATXI) Shares Are Getting Hammered - Avenue Therapeutics (NASDAQ:ATXI)
Benzinga
Avenue Therapeutics Inc. ATXI-2.50%. + Free Alerts. shares are trading lower by 28.5% to $0.09 during Wednesday's session after the company...
1 month ago
Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
Yahoo Finance
MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical...
2 months ago
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
GlobeNewswire
MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical...
2 months ago
Avenue Therapeutics announces 1-for-75 reverse stock split By Investing.com
Investing.com
MIAMI - Avenue Therapeutics, Inc. (NASDAQ:ATXI), a specialty pharmaceutical company, announced today that it will execute a 1-for-75 reverse...
1 month ago
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Yahoo Finance
Raised a total of $9.4 million in gross proceeds from warrant exercise transactions since January 2024 – MIAMI, May 15, 2024 (GLOBE...
1 month ago
Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol
GlobeNewswire
MIAMI, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical...
5 months ago